Ronald Hodge Sells 1,641 Shares of ReposiTrak (NYSE:TRAK) Stock

ReposiTrak Inc. (NYSE:TRAK) Director Ronald Hodge sold 1,641 shares of ReposiTrak stock in a transaction dated Monday, December 22nd. The shares were sold at an average price of $13.20, for a total transaction of $21,661.20. Following the sale, the director owned 580,775 shares in the company, valued at approximately $7,666,230. This represents a 0.28% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

ReposiTrak Stock Down 4.9%

Shares of TRAK opened at $12.25 on Wednesday. The firm has a market capitalization of $224.05 million, a PE ratio of 34.03 and a beta of 0.39. The firm has a 50-day moving average price of $14.01 and a 200 day moving average price of $16.12. ReposiTrak Inc. has a 52-week low of $12.16 and a 52-week high of $23.72.

ReposiTrak (NYSE:TRAK) last issued its quarterly earnings results on Thursday, November 13th. The company reported $0.09 earnings per share for the quarter. The company had revenue of $5.97 million during the quarter. ReposiTrak had a net margin of 30.52% and a return on equity of 14.37%.

Wall Street Analyst Weigh In

TRAK has been the topic of several research analyst reports. Weiss Ratings reiterated a “hold (c+)” rating on shares of ReposiTrak in a research report on Monday. Wall Street Zen cut ReposiTrak from a “buy” rating to a “hold” rating in a research note on Sunday, December 21st. One investment analyst has rated the stock with a Hold rating, According to MarketBeat, ReposiTrak has a consensus rating of “Hold”.

Hedge Funds Weigh In On ReposiTrak

Hedge funds have recently modified their holdings of the stock. BNP Paribas Financial Markets lifted its holdings in shares of ReposiTrak by 63.5% during the second quarter. BNP Paribas Financial Markets now owns 1,633 shares of the company’s stock valued at $32,000 after purchasing an additional 634 shares during the last quarter. Copeland Capital Management LLC acquired a new stake in ReposiTrak during the 3rd quarter worth about $54,000. Tower Research Capital LLC TRC lifted its stake in ReposiTrak by 397.3% during the second quarter. Tower Research Capital LLC TRC now owns 3,620 shares of the company’s stock valued at $71,000 after buying an additional 2,892 shares in the last quarter. GSA Capital Partners LLP purchased a new stake in ReposiTrak during the third quarter valued at about $219,000. Finally, R Squared Ltd acquired a new position in shares of ReposiTrak in the second quarter worth about $235,000. 27.35% of the stock is currently owned by institutional investors and hedge funds.

About ReposiTrak

ReposiTrak, trading on the New York Stock Exchange under the symbol TRAK, is a provider of cloud-based supply chain compliance and transparency solutions. The company’s platform enables retailers, suppliers and manufacturers to manage, share and validate product data throughout the supply chain. Through its Software-as-a-Service (SaaS) offering, ReposiTrak helps organizations ensure adherence to regulatory requirements, industry standards and retailer-specific guidelines for food safety, sustainability, labeling and quality assurance.

At the core of ReposiTrak’s offerings is its DataHub, a centralized repository that captures critical information such as product specifications, certifications, catch-weight data, temperature logs and recall notifications.